Literature DB >> 19766132

Sodium arsenite alters cell cycle and MTHFR, MT1/2, and c-Myc protein levels in MCF-7 cells.

Ruben Ruiz-Ramos1, Lizbeth López-Carrillo, Arnulfo Albores, Raúl U Hernández-Ramírez, Mariano E Cebrian.   

Abstract

There is limited available information on the effects of arsenic on enzymes participating in the folate cycle. Therefore, our aim was to evaluate the effects of sodium arsenite on the protein levels of methylenetetrahydrofolate reductase (MTHFR) and dihydrofolate reductase (DHFR) and its further relationship with the expression MT1/2 and c-myc in MCF-7 cells. Arsenite treatment (0-10 microM) for 4 h decreased MTHFR levels in a concentration-dependent fashion without significant effects on DHFR. The effects on MTHFR were observed at arsenite concentrations not significantly affecting cell viability. We also observed an increase in S-phase recruitment at all concentrations probed. Lower concentrations (<5 microM) induced cell proliferation, showing a high proportion of BrdU-stained cells, indicating a higher DNA synthesis rate. However, higher concentrations (> or =5 microM) or longer treatment periods induced apoptosis. Arsenite also induced dose-dependent increases in MT1/2 and c-Myc protein levels. The levels of MTHFR were inversely correlated to MT1/2 and c-Myc overexpression and increased S-phase recruitment. Our findings indicate that breast epithelial cells are responsive to arsenite and suggest that exposure may pose a risk for breast cancer. The reductions in MTHFR protein levels contribute to understand the mechanisms underlying the induction of genes influencing growth regulation, such as c-myc and MT1/2. However, further research is needed to ascertain if the effects here reported following short-time and high-dose exposure are relevant for human populations chronically exposed to low arsenic concentrations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766132     DOI: 10.1016/j.taap.2009.09.006

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

Review 1.  Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.

Authors:  Donato F Romagnolo; Kevin D Daniels; Jonathan T Grunwald; Stephan A Ramos; Catherine R Propper; Ornella I Selmin
Journal:  Mol Nutr Food Res       Date:  2016-06       Impact factor: 5.914

2.  Effects of arsenic sulfide (As2S2) on B and T lymphoma cell lines and possible underlying mechanisms.

Authors:  Xianglu Li; Xinyu Liu; Ling Wang; Xiao Lv; Peipei Li; Kang Lu; Xin Wang
Journal:  Biomed Rep       Date:  2013-05-30

3.  Metals and breast cancer: risk factors or healing agents?

Authors:  Ana-Maria Florea; Dietrich Büsselberg
Journal:  J Toxicol       Date:  2011-07-24

Review 4.  Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.

Authors:  Megan R Schwarzman; Janet M Ackerman; Shanaz H Dairkee; Suzanne E Fenton; Dale Johnson; Kathleen M Navarro; Gwendolyn Osborne; Ruthann A Rudel; Gina M Solomon; Lauren Zeise; Sarah Janssen
Journal:  Environ Health Perspect       Date:  2015-06-02       Impact factor: 9.031

Review 5.  Toxic elements as biomarkers for breast cancer: a meta-analysis study.

Authors:  Leila Jouybari; Marzieh Saei Ghare Naz; Akram Sanagoo; Faezeh Kiani; Fatemeh Sayehmiri; Kourosh Sayehmiri; Ali Hasanpour Dehkordi
Journal:  Cancer Manag Res       Date:  2018-01-10       Impact factor: 3.989

6.  Blood arsenic levels and the risk of familial breast cancer in Poland.

Authors:  Wojciech Marciniak; Róża Derkacz; Magdalena Muszyńska; Piotr Baszuk; Jacek Gronwald; Tomasz Huzarski; Cezary Cybulski; Anna Jakubowska; Michał Falco; Tadeusz Dębniak; Marcin Lener; Oleg Oszurek; Katherine Pullella; Joanne Kotsopoulos; Ping Sun; Steven A Narod; Jan Lubiński
Journal:  Int J Cancer       Date:  2019-08-26       Impact factor: 7.396

7.  Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.

Authors:  Ornella I Selmin; Micah G Donovan; Bethany Skovan; Gillian D Paine-Murieta; Donato F Romagnolo
Journal:  Int J Oncol       Date:  2019-01-15       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.